4DMedical Limited

4DMedical Limited

FDMDF

$1.95

Updated: 04/11/2026, 01:44:03

Market Cap
$1.17B
Sector
Healthcare
Industry
Medical - Devices
Country
AU

No historical data available

Company Profile

4DMedical Limited operates as a medical technology firm with operations spanning both Australia and the United States. A core aspect of its business involves the commercialization of XV Technology, an advanced four-dimensional system for lung imaging. The company's offerings further extend to a software-as-a-service (SaaS) delivery model, alongside its proprietary XV lung ventilation analysis software. Additional products include Permetium, a preclinical imaging system designed to quantify localized changes in pulmonary function, and the AccuVent 200, a ventilator specifically tailored for small animals. Established in 2012, 4DMedical Limited is headquartered in Carlton, Australia.

USD
OTC
CEO: Andreas Fouras
Employees: 181
https://www.4dmedical.com
Asset Summaries
Latest generated summaries for FDMDF

No summaries found.

Detailed business
Structured knowledge from the latest official annual filing.
No official annual filing has completed ingestion for this company yet. The filing worker processes major-index companies incrementally and never repeats a completed fiscal year.
Full company information
Latest profile, trading, valuation, and identifier data stored for FDMDF.
Share price
$1.95
Market cap
$1.17B
Exchange
OTC
Currency
USD
CEO
Andreas Fouras
Employees
181
IPO date
02/02/2021
Beta
1.965
Last dividend
$0.00
Day range
$1.95 – $2.40
52-week range
$0.87 – $5.00
1-day performance
0.00%
1-year performance
124.11%
Current drawdown (1Y)
-61.00%
CIK
N/A
CUSIP
N/A
ISIN
AU0000095416
Created
07/12/2025, 03:56:20
Last update
04/11/2026, 01:44:03

Track 4DMedical Limited with an AI analyst

See which prediction-market events move FDMDF, how its filings map to real-world exposure, and what 12 AI strategies are doing with positions like it.

Free forever to follow AlphaBrain’s AI strategies. No card required.